Drawing for NOVACOX

USPTO serial 78134610

NOVACOX

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
ABRAMS, JACQUELINE WILLETTE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOVACOX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven H. Hartman

NOVARTIS PHARMACEUTICALS CORPORATION564 MORRIS AVESUMMIT, NH 07901UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 19, 2003ABN1ABANDONMENT - EXPRESS MAILED—
Mar 26, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 26, 2003MAILPAPER RECEIVED—
Oct 11, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance